Skip to main content

Sonali Advani

Adjunct Associate Professor in the Department of Medicine
Medicine, Infectious Diseases
Hanes House Room 154, Box 102359, Durham, NC 27710

Overview


Dr. Advani is an Adjunct Associate Professor of Medicine at Duke University School of Medicine. In July 2024, she joined GSK/ViiV Healthcare as a scientific leadership physician with cross functional experience across global medical affairs as well as Research & Development in HIV therapeutics and vaccines.

Prior to this, she served as a physician investigator in the Duke Center for Antimicrobial Stewardship and Infection Prevention, a Fellow in Implementation Science at HIGH IRI (HIV, Infectious Disease and Global Health Implementation Research) Institute at Washington University, St Louis and Associate Medical Director of Infection Prevention at Yale New Haven Hospital. Her research focused on improving the diagnosis of UTIs in older adults, implementation of diagnostic stewardship interventions, and de-prescribing antibiotics for asymptomatic bacteriuria. She was awarded the K12 Urologic Career Development Award, Pepper Center Career Development Award, and SHEA Research Scholar Award to continue her UTI related research. In addition, she was one of the key investigators for CDC Prevention Epicenter Program and CDC SHEPheRD Contract for the Use of Race, Ethnicity, and Social Determinants of Health Data in NHSN Measures to Promote Health Equity.

Current Duke Appointments & Affiliations


Adjunct Associate Professor in the Department of Medicine · 2024 - Present Medicine, Infectious Diseases, Medicine

Recent News Items


Published July 27, 2019
Infectious Disease News
Inappropriate urine culture practices contribute to overdiagnosis of CAUTIs
Published April 14, 2019
Infectious Disease News
Q&A: The evolution of CAUTI and need for better metrics
Published February 19, 2019
IDSA Foundation
ID WOMEN OF THE FUTURE

View All News Items

Recent Scholarly Works


Efficacy of dolutegravir/lamivudine in adults with HIV-1 and isolated reactive hepatitis B core antibody: Insights from Phase 3/3b study results.

Journal article HIV Med · July 2026 OBJECTIVES: As two-drug HIV-1 antiretroviral therapy (ART) regimens become standard, data gaps remain concerning their safety and efficacy among people with isolated reactive hepatitis B core antibodies (anti-HBc). Here, we assessed the safety and efficacy ... Full text Link to item Cite

Racial disparities in healthcare-associated infections: a systematic review and meta-analysis.

Journal article Infect Control Hosp Epidemiol · April 24, 2026 OBJECTIVE: Racial and ethnic disparities in healthcare-associated infections (HAIs) could have significant implications for hospital-based incentive programs. We sought to quantify racial and ethnic disparities in HAIs across inpatients in the United State ... Full text Link to item Cite
View All Scholarly Works

Education


Johns Hopkins Unversity, Bloomberg School of Public Health · 2010 M.P.H.
Padmashree Dr. D. Y. Patil Medical College (India) · 2008 M.B.B.S.